With the advancements in medicare technology, over the centuries, innovations have flooded the healthcare sector. Medical professionals are also adopting modern and sophisticated minimally invasive surgeries while making sure that the wound-healing outcomes are not compromised.
With the rising incidences of chronic and age-related diseases in the world, primarily due to unhealthy lifestyles, stress, and alcohol abuse, the demand for the sutures in medicare facilities such as hospitals, surgical centers, clinics, and cardiovascular hospitals is very likely to touch the sky, taking the surgical suture market valuation to a staggering USD 4,751.7 million in 2024.
With the introduction of robotic arms and barbed sutures, more and more healthcare professionals are preferring sutures over staples and tapes. The market, which is estimated to grow at a modest CAGR of 4.20% has the potential to push the overall valuation to USD 7,170.1 million by the end of 2034.
Besides this, hefty investments by governments in the developing and underdeveloped parts of the world to medically safeguard their population are also bringing in a substantial amount of consumers to the market.
Attributes | Details |
---|---|
Market Value for 2024 | USD 4,751.7 million |
Projected Market Value for 2034 | USD 7,170.1 million |
Value-based CAGR of the Market for 2024 to 2034 | 4.20% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market is bifurcated into two: absorbable sutures and non-absorbable sutures on the basis of product type. Absorbable sutures are estimated to hold a market valuation of 61.70% as of 2024.
Attributes | Details |
---|---|
Product Type | Absorbable Surgical Sutures |
Market Share (2024) | 61.70% |
Absorbable surgical sutures are in great demand as they are designed to break down and be absorbed by the body over time. This eliminates the risk of complications such as infection and inflammation due to the absence of foreign materials in the body.
Another benefit, driving the adoption of absorbable sutures in the healthcare sector is that they eliminate the need for suture removal. Compared to traditional non-absorbable sutures that require a separate procedure for removal, these procedures provide more comfort and convenience to the patients.
On the basis of raw materials used in surgical procedures, the surgical suture market is segmented into synthetic and natural sutures. Among these, the synthetic ones are estimated to hold a market share of 51.60% in 2024.
Attributes | Details |
---|---|
Raw Material | Synthetic |
Market Share (2024) | 51.60% |
Hospitals, surgical centers, clinics, and emergency medicare facilities, are generating a huge demand for synthetic sutures as they offer consistent tensile strength and durability as compared to natural ones. This provides uniform performance and reliable wound closure and support.
The clamor for synthetic sutures has also touched the skies in the past few years as synthetic sutures, made from materials like nylon or polypropylene, are inert and less likely to cause allergic responses, making them suitable for a wider range of patients.
Countries | CAGR (2024 to 2034) |
---|---|
China | 6.90% |
India | 5.10% |
France | 4.00% |
United Kingdom | 3.70% |
Brazil | 3.60% |
The market in China is a promising one. It is slated to grow at a CAGR of 6.90% through 2034.
China has always been at the forefront of medical advancements right from the beginning of time. With the help of these innovations, Chinese healthcare facilities are able to bring non-invasive surgical methodologies for their residents that are not only effective but also affordable.
For instance, in September 2023, Chinese scientists synthesized ultra-tough spider silk from gene-edited silkworms, surpassing Kevlar's strength by sixfold. This breakthrough has the potential to revolutionize surgical sutures, offering stronger and eco-friendlier alternatives for medical procedures.
India is a lucrative country in this market. The market is envisioned to grow at a CAGR of 5.10% through the forecast period in India.
Indian government in the last few years has been curating a multitude of policies and schemes to medically include the majority of its underprivileged population in its healthcare policies. This benefits the market as it brings an enormous number of consumers to the market.
Indian companies with the help of their academia have also been able to bring novel innovations in the field of medical science. These innovations also contribute to the adoption of sophisticated medicare services, thus increasing the overall demand for surgical sutures in the country.
The future of the market in France looks bright. The market is slated to grow at a CAGR of 4.00% through 2034.
French companies involved in the manufacturing of surgical sutures are collaborating so that they can take advantage of each other’s areas of expertise. This is significantly benefitting the market as these collaborations not only increase the adoption of sutures but also make them more accessible and affordable in the market.
For example, in April 2024, Eurazeo finalized the sale of Peters Surgical, a top surgical sutures provider, to Advanced Medical Solutions Group plc. The sale marked the culmination of Eurazeo's support since 2013, facilitating Peters Surgical's expansion in France and globally.
The United Kingdom surgical suture market is slated to grow at a CAGR of 3.70% for the forecasted period of 2024 to 2034.
According to various health reports, one in six people in the United Kingdom currently have at least one chronic disease. This has automatically generated an excellent demand for surgical sutures as the treatment procedures for these diseases often include surgeries.
Besides this, government policies and well-established healthcare systems in the United Kingdom have also led to the increased reliance of people on sophisticated treatments. This has also surged the demand for surgical sutures in the country.
The Brazilian market is likely to flourish in the coming years. It is slated to grow at a CAGR of 3.60% through 2034.
Cosmetic surgeries have almost tripled in Brazil since the early 2010s. This is primarily due to Western beauty standards and the desire to look like Hollywood actresses and actors in affluent classes. These surgeries often require sophisticated and best-in-class surgical sutures, since they involve delicate facial procedures.
The surgical suture market is a well-established one as a multitude of companies and healthcare facilities have already created a strong foothold in the market. The prominence of these companies has considerably risen in the recent period as healthcare facilities, such as hospitals, ambulatory surgical centers, clinics, etc., rely heavily on their offerings.
To cater to the demands of eco-conscious consumers and businesses, these companies have also started investing heavily in the development of bio-degradable and natural surgical sutures.
Recent Developments
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is expected to be worth USD 4,751.7 million in 2024.
The market is expected to reach USD 7,170.1 million by 2034.
The market is set to develop at a CAGR of 4.20% from 2024 to 2034.
Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Consort Medical Plc (Bespak), Crossjet, and Medtronic plc, are some of the major players in the market.
The valuation of the market in 2023 was USD 4,583.3 million.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Surgical Sutures 5.2. Mechanical Sutures 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Suture Material 6.1. Absorbable Sutures 6.2. Non-Absorbable Sutures 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Filament 7.1. Monofilament/Barb Sutures 7.2. Multifilament/Braided Sutures 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Raw Material 8.1. Natural Sutures 8.1.1. Silk Sutures 8.1.2. Catgut Sutures 8.2. Synthetic Sutures 8.2.1. Polyglactin 910 Sutures 8.2.2. Polyglecaprone 25 Sutures 8.2.3. Polydioxanone Sutures 8.2.4. Polyglycolic Acid Sutures 8.2.5. Nylon Sutures 8.2.6. Prolene Sutures 8.2.7. Stainless Steel Sutures 8.2.8. Others 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Coating 9.1. Coated Sutures 9.2. Non-Coated Sutures 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 10.1. General Surgery 10.2. Gynecology Surgery 10.3. Orthopedic Surgery 10.4. Ophthalmic Surgery 10.5. Cosmetic & Plastic Surgery 10.6. Cardiac Surgery 10.7. Others Applications 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 11.1. Hospitals 11.2. Specialized Clinics 11.3. Ambulatory Surgical Centres 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 12.1. North America 12.2. Latin America 12.3. Western Europe 12.4. Eastern Europe 12.5. South Asia and Pacific 12.6. East Asia 12.7. Middle East and Africa 13. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 17. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 18. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 19. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 20. Key Countries Market Analysis 21. Market Structure Analysis 22. Competition Analysis 22.1. B.Braun Melsungen AG 22.2. Johnson & Johnson (Ethicon) 22.3. CP Medical 22.4. Atramat 22.5. Medtronic 22.6. DemeTECH Corporation 22.7. Teleflex Incorporated 22.8. Kono Seisakusho Co., Ltd 22.9. Mani Inc. 22.10. Dynek Pvt Ltd. 23. Assumptions & Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports